全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1849590-01-7 | 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione | C17H20N6O2 |
| 1849594-85-9 | 5-Bromo-1,6-dihydro-3-methyl-6-oxo-2-pyridinecarboxylic acid ethyl ester | C9H10BrNO3 |
| 1850305-79-1 | N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl]carbamic acid 1,1-dimethylethyl ester | C13H26BNO4 |
| 1850305-80-4 | N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl]carbamic acid 1,1-dimethylethyl ester | C14H28BNO4 |
| 1853997-27-9 | 2-(4-Bromo-1-naphthalenyl)-1,10-phenanthroline | C22H13BrN2 |
| 1854067-25-6 | (R)-1-[(S)-2-(2'-Diphenyphosphinophenyl)ferrocenyl]ethyldiphenylphosphine | C42H31FeP2 |
| 1854067-37-0 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(diphenylphosphino)phenyl]ferrocene;Walphos SL-W012-2 | C38H44FeP2 |
| 1854067-50-7 | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene;Walphos SL-W029-1 | C38H56FeP2 |
| 1854067-58-5 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene;Walphos SL-W029-2 | C38H56FeP2 |
| 1854067-62-1 | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene;Walphos SL-W030-1 | C34H52FeP2 |
| 1854067-71-2 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene;Walphos SL-W030-2 | C34H52FeP2 |
| 1855006-12-0 | Regorafenib EP Impurity C;4-(3-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide | C20H18FN5O3 |
| 1855920-54-5 | 3-chloro Rivaroxaban;3-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide | C19H18ClN3O5S |
| 1859053-21-6 | (1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid compd. with 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1) | C19H18FN3O.C10H16O4S |
| 1859162-80-3 | Sofosbuvir Impurity 93;[(2R,3R,4R,5R)-5-(2,4-dioxo-1,3-diazinan-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methyl phenyl hydrogen phosphate | C16H20FN2O8P |
| 1860012-45-8 | tert-Butyl N-[(2S,3S)-2-methylpiperidin-3-yl]carbamate | C11H22N2O2 |
| 1860012-52-7 | (3R,5S)-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1860793-92-5 | Hexahydro-6-(phenylmethyl)-pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | C14H17N3O2 |
| 1862216-82-7 | Ethyl 9-phenyl-9H-carbazole-3-carboxylate | C21H17NO2 |
| 1863098-74-1 | Cyclopropyl(4,6-dichloropyridin-3-yl)methanonethanone | C9H7Cl2NO |
| 1863930-34-0 | Azilsartan Impurity F;ethyl 3-amino-2-[[4-(2-carbamoylphenyl)phenyl]methylamino]benzoate | C23H23N3O3 |
| 1864897-67-5 | 2-Hydroxy-N-(pyridin-4-yl)butanamide | C9H12N2O2 |
| 1868064-50-9 | Abiraterone Acetate 5,6-Epoxide;[(1S,2R,5S,7R,9S,11S,12S,16S)-2,16-dimethyl-15-pyridin-3-yl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-14-en-5-yl] acetate | C26H33NO3 |
| 1868232-32-9 | (R)-N-Cyclohexyl-3-[(3,4-dichlorophenethyl)amino]-N-[2-[[2-hydroxy-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl]amino]ethyl]propanamide | C29H38Cl2N4O4 |
| 1869075-89-7 | Bendamustine USP Related Compound F;[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoate | C22H33Cl2N3O7 |
| 1869118-24-0 | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester;ethyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate | C16H16N4O4S |
| 1870821-29-6 | (S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline | C16H14BrCl2N |
| 1872382-47-2 | N-[4-(1,1-Dimethylethyl)benzoyl]-L-phenylalanyl-L-alanyl-L-leucyl-N6,N6-diethyl-L-lysyl-L-serine methyl ester | C43H66N6O8 |
| 1872435-00-1 | Leuprolide Acetate EP Impurity F;N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid | C61H85F3N16O14 |
| 1874276-76-2 | 3-Amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide | C22H23F3N8O |
| 1876467-74-1 | 2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine | C20H21N7O |
| 1878105-23-7 | N-XantPhos Pd G4;(SP-4-4)-[4-(Diphenylphosphino-?P)-6-(diphenylphosphino)-10H-phenoxazine](methanesulfonato-?O)[2'-(methylamino-?N)[1,1'-biphenyl]-2-yl-?C]palladium | C50H43N2O4P2PdS- |
| 1882873-21-3 | Lenvatinib Impurity 16;1-[2-chloro-4-(6-cyano-7-methoxyquinolin-4-yl)oxyphenyl]-3-cyclopropylurea | C21H17ClN4O3 |
| 1883265-36-8 | 2-([1,1'-Biphenyl]-3-yl)-4-chloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine | C27H16ClN3O |
| 1883299-62-4 | Brepocitinib;[(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone | C18H21F2N7O |
| 1883377-30-7 | 8-[4-(2,2-Dimethylpropyl)-2-pyridinyl]-2-(methyl)-benzofuro[2,3-b]pyridine | C22H22N2O |
| 1883423-59-3 | [(2S)-2-(4-Chlorophenyl)-1-pyrrolidinyl](3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone | C18H17ClN4O |
| 1883429-22-8 | 4-(4-((Dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one;BI 9564 | C20H23N3O3 |
| 1883563-86-7 | Tenofovir Related Compound 8;methane;propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-[[(2S)-1-oxo-1-propan-2-yloxypropan-2-yl]amino]phosphoryl]amino]propanoate | C22H40N7O6P |
| 1883595-38-7 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic acid | C11H8FNO2 |
| 1883681-10-4 | Azilsartan Impurity 21;3-Hydroxy-2-oxobutyl azilsartan ester | C29H26N4O7 |
| 1887009-48-4 | (S)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride;3-[(1S)-1-aminoethyl]-6-chloro-1H-quinolin-2-one;hydrochloride | C11H12Cl2N2O |
| 1887009-51-9 | (R)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride | C11H12Cl2N2O |
| 1887015-55-5 | 5-Fluoro-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile | C7H5FN2O |
| 1887057-05-7 | Docetaxel EP Impurity A;2-O-desbenzoyl-2-O-tiglyldocetaxel | C41H55NO14 |
| 1887742-42-8 | Adb-fubinaca metabolite M3;N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1H-indazole-3-carboxamide | C14H18N4O2 |
| 1888294-91-4 | 2,3,4,5-Tetrahydro-1-[2-methyl-4-(3-methyl-1H-pyrazol-1-yl)benzoyl]-5-oxo-1H-1-benzazepine-4-carboxylic acid ethyl ester | C25H25N3O4 |
| 1888438-11-6 | 9-([1,1'-Biphenyl]-4-yl)-9'-(triphenylen-2-yl)-9H,9'H-3,3'-bicarbazole;3-[9-(4-phenylphenyl)carbazol-3-yl]-9-triphenylen-2-ylcarbazole | C54H34N2 |
| 1888438-12-7 | 9-[1,1'-Biphenyl]-3-YL-9'-(2-triphenylenyl)-3,3'-BI-9H-carbazole;3-[9-(3-phenylphenyl)carbazol-3-yl]-9-triphenylen-2-ylcarbazole | C54H34N2 |
| 1888902-20-2 | 4-Chloro-7-isoquinolinol | C9H6ClNO |